| Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock Z Bikadi, E Hazai Journal of cheminformatics 1, 1-16, 2009 | 756 | 2009 |
| Reduction of toxic metabolite formation of acetaminophen E Hazai, L Vereczkey, K Monostory Biochemical and biophysical research communications 291 (4), 1089-1094, 2002 | 164 | 2002 |
| Evaluation of drug–human serum albumin binding interactions with support vector machine aided online automated docking F Zsila, Z Bikadi, D Malik, P Hari, I Pechan, A Berces, E Hazai Bioinformatics 27 (13), 1806-1813, 2011 | 154 | 2011 |
| Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein Z Bikadi, I Hazai, D Malik, K Jemnitz, Z Veres, P Hari, Z Ni, TW Loo, ... PloS one 6 (10), e25815, 2011 | 131 | 2011 |
| Functional and structural characterization of a protein based on analysis of its hydrogen bonding network by hydrogen bonding plot Z Bikadi, L Demko, E Hazai Archives of Biochemistry and Biophysics 461 (2), 225-234, 2007 | 125 | 2007 |
| Homology modeling of breast cancer resistance protein (ABCG2) E Hazai, Z Bikádi Journal of structural biology 162 (1), 63-74, 2008 | 112 | 2008 |
| Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes M Broekgaarden, R Weijer, M Krekorian, B van den IJssel, M Kos, ... Nano Research 9, 1639-1662, 2016 | 86 | 2016 |
| Disordered proteins and network disorder in network descriptions of protein structure, dynamics and function: hypotheses and a comprehensive review P Csermely, K Singh Sandhu, E Hazai, Z Hoksza, H JM Kiss, F Miozzo, ... Current Protein and Peptide Science 13 (1), 19-33, 2012 | 74 | 2012 |
| Natural product inspired antibacterial tetramic acid libraries with dual enzyme inhibition YC Jeong, M Anwar, Z Bikadi, E Hazai, MG Moloney Chemical Science 4 (3), 1008-1015, 2013 | 64 | 2013 |
| Interactions between CYP2C9 and CYP2C19 in reconstituted binary systems influence their catalytic activity: possible rationale for the inability of CYP2C19 to catalyze … E Hazai, D Kupfer Drug metabolism and disposition 33 (1), 157-164, 2005 | 62 | 2005 |
| Binding of the pepper alkaloid piperine to bovine β-lactoglobulin: circular dichroism spectroscopy and molecular modeling study F Zsila, E Hazai, L Sawyer Journal of agricultural and food chemistry 53 (26), 10179-10185, 2005 | 61 | 2005 |
| Predicting substrates of the human breast cancer resistance protein using a support vector machine method E Hazai, I Hazai, I Ragueneau-Majlessi, SP Chung, Z Bikadi, Q Mao BMC bioinformatics 14, 1-7, 2013 | 60 | 2013 |
| Identification of a polyoxometalate inhibitor of the DNA binding activity of Sox2 K Narasimhan, S Pillay, NR Bin Ahmad, Z Bikadi, E Hazai, L Yan, ... ACS chemical biology 6 (6), 573-581, 2011 | 60 | 2011 |
| Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenase E Hazai, Z Bikádi, F Zsila, SF Lockwood Bioorganic & medicinal chemistry 14 (20), 6859-6867, 2006 | 52 | 2006 |
| Aggregation of cyclodextrins as an important factor to determine their complexation behavior Z Bikádi, R Kurdi, S Balogh, J Szemán, E Hazai Chemistry & biodiversity 3 (11), 1266-1278, 2006 | 48 | 2006 |
| Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors K Monostory, E Hazai, L Vereczkey Chemico-biological interactions 147 (3), 331-340, 2004 | 48 | 2004 |
| Interactions of granisetron with an agonist-free 5-HT3A receptor model PR Joshi, A Suryanarayanan, E Hazai, MK Schulte, G Maksay, Z Bikádi Biochemistry 45 (4), 1099-1105, 2006 | 44 | 2006 |
| Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun-and lyophilized formulations L Szente, I Puskás, T Sohajda, E Varga, P Vass, ZK Nagy, A Farkas, ... Carbohydrate Polymers 264, 118011, 2021 | 40 | 2021 |
| Molecular modeling of non-covalent binding of homochiral (3S, 3′ S)-astaxanthin to matrix metalloproteinase-13 (MMP-13) Z Bikádi, E Hazai, F Zsila, SF Lockwood Bioorganic & medicinal chemistry 14 (16), 5451-5458, 2006 | 39 | 2006 |
| Selective binding of coumarin enantiomers to human α1-acid glycoprotein genetic variants E Hazai, J Visy, I Fitos, Z Bikádi, M Simonyi Bioorganic & medicinal chemistry 14 (6), 1959-1965, 2006 | 39 | 2006 |
Zsolt BikadiChief Scientific Officer, Virtua Drug Ltd在 virtuadrug.com 的电子邮件经过验证
